El-Megiri, N.; Mostafa, Y.M.; Ahmed, A.; Mehanna, E.T.; El-Azab, M.F.; Alshehri, F.; Alahdal, H.; El-Sayed, N.M.
Pioglitazone Ameliorates Hippocampal Neurodegeneration, Disturbances in Glucose Metabolism and AKT/mTOR Signaling Pathways in Pentyelenetetrazole-Kindled Mice. Pharmaceuticals 2022, 15, 1113.
https://doi.org/10.3390/ph15091113
AMA Style
El-Megiri N, Mostafa YM, Ahmed A, Mehanna ET, El-Azab MF, Alshehri F, Alahdal H, El-Sayed NM.
Pioglitazone Ameliorates Hippocampal Neurodegeneration, Disturbances in Glucose Metabolism and AKT/mTOR Signaling Pathways in Pentyelenetetrazole-Kindled Mice. Pharmaceuticals. 2022; 15(9):1113.
https://doi.org/10.3390/ph15091113
Chicago/Turabian Style
El-Megiri, Nada, Yasser M. Mostafa, Amal Ahmed, Eman T. Mehanna, Mona F. El-Azab, Fatma Alshehri, Hadil Alahdal, and Norhan M. El-Sayed.
2022. "Pioglitazone Ameliorates Hippocampal Neurodegeneration, Disturbances in Glucose Metabolism and AKT/mTOR Signaling Pathways in Pentyelenetetrazole-Kindled Mice" Pharmaceuticals 15, no. 9: 1113.
https://doi.org/10.3390/ph15091113
APA Style
El-Megiri, N., Mostafa, Y. M., Ahmed, A., Mehanna, E. T., El-Azab, M. F., Alshehri, F., Alahdal, H., & El-Sayed, N. M.
(2022). Pioglitazone Ameliorates Hippocampal Neurodegeneration, Disturbances in Glucose Metabolism and AKT/mTOR Signaling Pathways in Pentyelenetetrazole-Kindled Mice. Pharmaceuticals, 15(9), 1113.
https://doi.org/10.3390/ph15091113